|
市場調査レポート
商品コード
1672078
静脈血栓塞栓症治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）Global Venous Thromboembolism Treatment Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033 |
||||||
カスタマイズ可能
|
|||||||
| 静脈血栓塞栓症治療の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年） |
|
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
静脈血栓塞栓症治療の世界市場規模は、2024年の18億1,000万米ドルから2033年には27億米ドルに成長し、2026年から2033年の予測期間中に4.53％の堅調な年間平均成長率（CAGR）を示すと予測されます。
静脈血栓塞栓症（VTE）治療市場は、深部静脈血栓症（DVT）や肺塞栓症（PE）を含むVTE疾患の有病率の増加に牽引され、大きな成長を遂げています。深部静脈血栓症（DVT）や肺塞栓症（PE）を含むVTE疾患の有病率が上昇していることが背景にあり、VTEに関連するリスクに対する認識が高まるにつれて、ヘルスケアプロバイダーは効果的な予防・治療戦略を優先するようになっています。直接経口抗凝固薬（DOAC）や従来の抗凝固薬を含む抗凝固療法に対する需要が急増しており、臨床医は患者の予後を改善し、VTE関連の合併症の発生率を低下させようとしています。
治療オプションと投与方法の革新がVTE治療市場の将来を形成しています。安全性プロファイルと投与レジメンを改善した新規抗凝固薬の開発は、VTE管理の治療状況を向上させています。さらに、ウェアラブルデバイスや遠隔医療ソリューションなどの患者モニタリング技術の進歩により、ヘルスケアプロバイダーは患者のアドヒアランスと転帰をより効果的に追跡できるようになっています。VTEの根本的なメカニズムの研究が進むにつれて、特定の危険因子や患者集団に対処する標的治療のイントロダクションが市場に導入されるようになるでしょう。
さらに、製薬企業や学術機関がこの分野におけるアンメットニーズを認識していることから、VTE治療市場は臨床研究開発への投資増加の恩恵を受けるでしょう。臨床試験を進め、革新的な治療法を成功させるためには、ヘルスケアプロバイダー、研究者、および業界の利害関係者の協力が不可欠です。規制状況の進展に伴い、規制機関は新たな治療法の承認プロセスを合理化し、VTE患者のための効果的な解決策への迅速なアクセスを促進することが期待されます。今後はVTE管理を包括的なヘルスケア戦略に統合する方向にますます焦点が移行し、患者の転帰を改善するための予防、早期発見、個別化された治療計画の重要性が強調されるでしょう。
当社のレポートは、様々な業界や市場に関する包括的かつ実用的な洞察をお客様に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます：
市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。
市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。
セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。
競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場プレイヤーの包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。
市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。
地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。
新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 静脈血栓塞栓症治療の産業分析
- イントロダクション-市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカーリスト
- 主要原材料の価格動向
- 潜在的バイヤーリスト
- マーケティングチャネル
- ダイレクトマーケティング
- インダイレクトマーケティング
- マーケティングチャネル発展動向
第5章 静脈血栓塞栓症治療の世界市場分析：製品別
- 製品別の概要
- 製品別の過去および予測データ分析
- 非分割型空気圧縮ポンプ
- セグメント化された勾配なし空気圧圧縮ポンプ
- 較正勾配付き分割型空気圧圧縮ポンプ
- 上部空気圧圧縮スリーブ
- 下部空気圧圧縮スリーブ
- 永久下大静脈フィルター
- 回収可能な下大静脈フィルター
- 塞栓バルーンカテーテル
- 経皮的血栓除去装置
- カテーテル直接血栓溶解（CDT）デバイス
第6章 静脈血栓塞栓症治療の世界市場分析：疾患別
- 疾患別の概要
- 疾患別の過去および予測データ分析
- 深部静脈血栓症
- 肺塞栓症
第7章 静脈血栓塞栓症治療の世界市場分析：エンドユーザー別
- エンドユーザー別の概要
- エンドユーザー別の過去および予測データ分析
- 病院
- カテーテル検査室
- 外来手術センター
第8章 静脈血栓塞栓症治療の世界市場分析：地域別
- 地域別の展望
- イントロダクション
- 北米の売上分析
- 概要、実績と予測
- 北米：セグメント別
- 北米：国別
- 米国
- カナダ
- メキシコ
- 欧州の売上分析
- 概要、実績と予測
- 欧州：セグメント別
- 欧州：国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他欧州
- アジア太平洋の売上分析
- 概要、実績と予測
- アジア太平洋：セグメント別
- アジア太平洋：国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他アジア太平洋
- ラテンアメリカの売上分析
- 概要、実績と予測
- ラテンアメリカ：セグメント別
- ラテンアメリカ：国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他ラテンアメリカ
- 中東・アフリカの売上分析
- 概要、実績と予測
- 中東・アフリカ：セグメント別
- 中東・アフリカ：国別
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
第9章 静脈血栓塞栓症治療企業の競合情勢
- 静脈血栓塞栓症治療の市場競争
- 提携/協力/合意
- 合併・買収
- 新製品の発売
- その他の開発
第10章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Stryker Corporation
- Argon Medical Devices
- Cardinal Health（Medtronic）
- Cook Medical
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Arjo
- DJO Global
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Product (Units and USD MN)
- Non-Segmented Pneumatic Compression Pumps Market Sales By Geography (Units and USD MN)
- Segmented Pneumatic Compression Pumps without Gradient Market Sales By Geography (Units and USD MN)
- Segmented Pneumatic Compression Pumps with Calibrated Gradient Market Sales By Geography (Units and USD MN)
- Upper Pneumatic Compression Sleeves Market Sales By Geography (Units and USD MN)
- Lower Pneumatic Compression Sleeves Market Sales By Geography (Units and USD MN)
- Permanent Inferior Vena Cava Filters Market Sales By Geography (Units and USD MN)
- Retrievable Inferior Vena Cava Filters Market Sales By Geography (Units and USD MN)
- Embolectomy Balloon Catheters Market Sales By Geography (Units and USD MN)
- Percutaneous Thrombectomy Devices Market Sales By Geography (Units and USD MN)
- Catheter-Directed Thrombolysis (CDT) Devices Market Sales By Geography (Units and USD MN)
- Analysis By Disease Indication (Units and USD MN)
- Deep Venous Thrombosis Market Sales By Geography (Units and USD MN)
- Pulmonary Embolism Market Sales By Geography (Units and USD MN)
- Analysis By End User (Units and USD MN)
- Hospitals Market Sales By Geography (Units and USD MN)
- Catheterisation Laboratories Market Sales By Geography (Units and USD MN)
- Ambulatory Surgical Centres Market Sales By Geography (Units and USD MN)
- Global Venous Thromboembolism Treatment Market Sales By Geography (Units and USD MN)
- North America Market Analysis (Units and USD MN)
- United States Market Analysis (Units and USD MN)
- Canada Market Analysis (Units and USD MN)
- Mexico Market Analysis (Units and USD MN)
- Europe Market Analysis (Units and USD MN)
- Europe Market Estimate By Country (Units and USD MN)
- United Kingdom Market Analysis (Units and USD MN)
- France Market Analysis (Units and USD MN)
- Germany Market Analysis (Units and USD MN)
- Italy Market Analysis (Units and USD MN)
- Russia Market Analysis (Units and USD MN)
- Spain Market Analysis (Units and USD MN)
- Rest of Europe Market Analysis (Units and USD MN)
- Asia Pacific Market Analysis (Units and USD MN)
- China Market Analysis (Units and USD MN)
- Japan Market Analysis (Units and USD MN)
- India Market Analysis (Units and USD MN)
- South Korea Market Analysis (Units and USD MN)
- Australia Market Analysis (Units and USD MN)
- South East Asia Market Analysis (Units and USD MN)
- Rest of Asia Pacific Market Analysis (Units and USD MN)
- Latin America Market Analysis (Units and USD MN)
- Brazil Market Analysis (Units and USD MN)
- Argentina Market Analysis (Units and USD MN)
- Peru Market Analysis (Units and USD MN)
- Chile Market Analysis (Units and USD MN)
- Rest of Latin America Market Analysis (Units and USD MN)
- Middle East & Africa Market Analysis (Units and USD MN)
- Saudi Arabia Market Analysis (Units and USD MN)
- UAE Market Analysis (Units and USD MN)
- Israel Market Analysis (Units and USD MN)
- South Africa Market Analysis (Units and USD MN)
- Rest of Middle East and Africa Market Analysis (Units and USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of Venous Thromboembolism Treatment Report
- Market Research Process
- Market Research Methodology
- Global Venous Thromboembolism Treatment Market Size, By Region (Units and USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Product
- Market Attractiveness Analysis By Disease Indication
- Market Attractiveness Analysis By End User
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Product (Units and USD MN)
- Non-Segmented Pneumatic Compression Pumps Market Sales By Geography (Units and USD MN)
- Segmented Pneumatic Compression Pumps without Gradient Market Sales By Geography (Units and USD MN)
- Segmented Pneumatic Compression Pumps with Calibrated Gradient Market Sales By Geography (Units and USD MN)
- Upper Pneumatic Compression Sleeves Market Sales By Geography (Units and USD MN)
- Lower Pneumatic Compression Sleeves Market Sales By Geography (Units and USD MN)
- Permanent Inferior Vena Cava Filters Market Sales By Geography (Units and USD MN)
- Retrievable Inferior Vena Cava Filters Market Sales By Geography (Units and USD MN)
- Embolectomy Balloon Catheters Market Sales By Geography (Units and USD MN)
- Percutaneous Thrombectomy Devices Market Sales By Geography (Units and USD MN)
- Catheter-Directed Thrombolysis (CDT) Devices Market Sales By Geography (Units and USD MN)
- Global Market Analysis By Disease Indication (Units and USD MN)
- Deep Venous Thrombosis Market Sales By Geography (Units and USD MN)
- Pulmonary Embolism Market Sales By Geography (Units and USD MN)
- Global Market Analysis By End User (Units and USD MN)
- Hospitals Market Sales By Geography (Units and USD MN)
- Catheterisation Laboratories Market Sales By Geography (Units and USD MN)
- Ambulatory Surgical Centres Market Sales By Geography (Units and USD MN)
- Global Market Sales (Units and USD MN)
- North America Market Sales (Units and USD MN)
- Europe Market Sales (Units and USD MN)
- Asia Pacific Market Sales (Units and USD MN)
- Latin America Market Sales (Units and USD MN)
- Middle East & Africa Market Sales (Units and USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
- Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Global Venous Thromboembolism Treatment Market size is anticipated to grow from USD 1.81 Billion in 2024 to USD 2.7 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.53% during the forecast period of 2026 to 2033.
The venous thromboembolism (VTE) treatment market is experiencing significant growth, driven by the increasing prevalence of VTE conditions, including deep vein thrombosis (DVT) and pulmonary embolism (PE). As awareness of the risks associated with VTE rises, healthcare providers are prioritizing effective prevention and treatment strategies. The market is witnessing a surge in demand for anticoagulant therapies, including direct oral anticoagulants (DOACs) and traditional anticoagulants, as clinicians seek to improve patient outcomes and reduce the incidence of VTE-related complications.
Innovations in treatment options and delivery methods are shaping the future of the VTE treatment market. The development of novel anticoagulant agents with improved safety profiles and dosing regimens is enhancing the therapeutic landscape for VTE management. Additionally, advancements in patient monitoring technologies, such as wearable devices and telehealth solutions, are enabling healthcare providers to track patient adherence and outcomes more effectively. As research continues to explore the underlying mechanisms of VTE, the market is likely to witness the introduction of targeted therapies that address specific risk factors and patient populations.
Moreover, the VTE treatment market will benefit from increased investment in clinical research and development, as pharmaceutical companies and academic institutions recognize the unmet needs in this area. Collaborative efforts between healthcare providers, researchers, and industry stakeholders will be essential in advancing clinical trials and ensuring the successful implementation of innovative therapies. As the landscape evolves, regulatory bodies are expected to streamline approval processes for new treatments, facilitating faster access to effective solutions for patients with VTE. The focus will increasingly shift towards integrating VTE management into comprehensive healthcare strategies, emphasizing the importance of prevention, early detection, and personalized treatment plans in improving patient outcomes.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
SEGMENTATION COVERED IN THE REPORT
By Product
- Non-Segmented Pneumatic Compression Pumps
- Segmented Pneumatic Compression Pumps without Gradient
- Segmented Pneumatic Compression Pumps with Calibrated Gradient
- Upper Pneumatic Compression Sleeves
- Lower Pneumatic Compression Sleeves
- Permanent Inferior Vena Cava Filters
- Retrievable Inferior Vena Cava Filters
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Catheter-Directed Thrombolysis (CDT) Devices
By Disease Indication
- Deep Venous Thrombosis
- Pulmonary Embolism
By End User
- Hospitals
- Catheterisation Laboratories
- Ambulatory Surgical Centres
- COMPANIES PROFILED
- Stryker Corporation
- Argon Medical Devices
- Cardinal Health (Medtronic)
- Cook Medical
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Arjo
- DJO Global
- The above list can be customized.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. VENOUS THROMBOEMBOLISM TREATMENT INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porters Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Disease Indication
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY PRODUCT
- 5.1. Overview By Product
- 5.2. Historical and Forecast Data Analysis By Product
- 5.3. Non-Segmented Pneumatic Compression Pumps Historic and Forecast Sales By Regions
- 5.4. Segmented Pneumatic Compression Pumps without Gradient Historic and Forecast Sales By Regions
- 5.5. Segmented Pneumatic Compression Pumps with Calibrated Gradient Historic and Forecast Sales By Regions
- 5.6. Upper Pneumatic Compression Sleeves Historic and Forecast Sales By Regions
- 5.7. Lower Pneumatic Compression Sleeves Historic and Forecast Sales By Regions
- 5.8. Permanent Inferior Vena Cava Filters Historic and Forecast Sales By Regions
- 5.9. Retrievable Inferior Vena Cava Filters Historic and Forecast Sales By Regions
- 5.10. Embolectomy Balloon Catheters Historic and Forecast Sales By Regions
- 5.11. Percutaneous Thrombectomy Devices Historic and Forecast Sales By Regions
- 5.12. Catheter-Directed Thrombolysis (CDT) Devices Historic and Forecast Sales By Regions
6. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY DISEASE INDICATION
- 6.1. Overview By Disease Indication
- 6.2. Historical and Forecast Data Analysis By Disease Indication
- 6.3. Deep Venous Thrombosis Historic and Forecast Sales By Regions
- 6.4. Pulmonary Embolism Historic and Forecast Sales By Regions
7. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY END USER
- 7.1. Overview By End User
- 7.2. Historical and Forecast Data Analysis By End User
- 7.3. Hospitals Historic and Forecast Sales By Regions
- 7.4. Catheterisation Laboratories Historic and Forecast Sales By Regions
- 7.5. Ambulatory Surgical Centres Historic and Forecast Sales By Regions
8. GLOBAL VENOUS THROMBOEMBOLISM TREATMENT MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE VENOUS THROMBOEMBOLISM TREATMENT COMPANIES
- 9.1. Venous Thromboembolism Treatment Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF VENOUS THROMBOEMBOLISM TREATMENT INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Stryker Corporation
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Argon Medical Devices
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. Cardinal Health (Medtronic)
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Cook Medical
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. Boston Scientific Corporation
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. Koninklijke Philips N.V.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Arjo
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. DJO Global
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
